(Q39500659)

12 September 2017

title

25 mg oestradiol implants--the dosage of first choice for subcutaneous oestrogen replacement therapy? (English)

1 reference

12 September 2017

McGarrigle HT

3

1 reference

12 September 2017

E. J. Owen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1327094

14 September 2022

N. C. Siddle

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1327094

14 September 2022

H. T. McGarrigle

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1327094

14 September 2022

M. A. Pugh

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1327094

14 September 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1327094

14 September 2022

publication date

1 August 1992

1 reference

British Journal of Obstetrics and Gynaecology

12 September 2017

published in

1 reference

12 September 2017

volume

99

1 reference

12 September 2017

issue

8

1 reference

12 September 2017

page(s)

671-675

1 reference

10.1111/J.1471-0528.1992.TB13853.X

12 September 2017

Identifiers

DOI

0 references

1 reference